Neuropilins在肿瘤中的多功能作用机制

doi:10.3969/j.issn.1009-976X.2020.04.030

摘要/Abstract

摘要： 神经纤毛蛋白（NRPs）是一种调控胚胎组织发育、体内稳态以及癌症进展的跨膜糖蛋白。这篇综述讨论NRPs在各种癌症中的功能及其潜在机制,重点是NRPs在多功能细胞因子转化生长因子-β1（TGF-β1）信号传导途径、上皮-间质转化（EMT）、癌症干细胞（CSC）特性和药物抵抗调节中的作用,探讨NRPs调节作用如何促进细胞可塑性、肿瘤进展及转移。最后,讨论了NRPs在靶向治疗中的广泛应用前景。

关键词: 癌症干细胞, 1, 转化生长因子-β, 神经纤毛蛋白, 上皮-间质转化

Abstract: Neuropilins （NRPs） are transmembrane glycoproteins that regulates embryo tissue development, homeostasis, and cancer progression. The purpose of this review article is to discuss the function and potential mechanism of NRPs in various cancers, especially in the multifunctional cytokine transforming growth factor-β1 （TGF-β1） signaling pathway and Epithelial-Mesenchymal Transition （EMT）. The characteristics of cancer stem cells （CSC） and the role of drug resistance regulation, explore how NRPs regulation can promote cell plasticity, tumor progression and metastasis. Finally, discuss the broad application prospects of NRPs in targeted therapy.

Key words: transforming growth factor-β1, cancer stem cells （CSCs）, epithelial-mesenchymal transition, neuropilins

中图分类号:

刘想梅, 徐卫国. Neuropilins在肿瘤中的多功能作用机制[J]. 岭南现代临床外科, 2020, 20(04): 540-544.

LIU Xiang-mei, XU Wei-guo. Multifunctional mechanism of neuropilins in tumor[J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 540-544.

参考文献

[1] Narayanan N, Su N, Bedard P.Inhibitory and stimulatory effects of fluoride on the calcium pump of cardiac sarcoplasmic reticulum[J]. Biochim Biophys Acta, 1991, 1070(1): 83-91.
[2] Nakamura F, Goshima Y.Structural and functional relation of neuropilins[J]. Adv Exp Med Biol, 2002, 515: 55-69.
[3] Bagci T, Wu JK, Pfannl R, et al.Autocrine semaphorin 3A signaling promotes glioblastoma dispersal[J]. Oncogene, 2009, 28(40): 3537-3550.
[4] Hu B, Guo P, Bar-Joseph I, et al.Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway[J]. Oncogene, 2007, 26(38): 5577-5586.
[5] Yaqoob U, Cao S, Shergill U, et al.Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment[J]. Cancer Res, 2012, 72(16): 4047-4059.
[6] Gurrapu S, Tamagnone L.Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells[J]. Trend Mol Med, 2019, 25(4): 303-314.
[7] Das V, Bhattacharya S, Chikkaputtaiah C, et al.The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective[J]. J Cell Physiol, 2019. doi: 10.1002/jcp.28160.
[8] Matkar PN, Jong ED, Ariyagunarajah R, et al.Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer[J]. Cancer Med, 2018, 7(10): 5036-5046.
[9] Yamazaki K, Masugi Y, Sakamoto M.Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-beta signaling in hepatocarcinogenesis[J]. J Cell Biochem, 2011, 29(3): 284-288.
[10] Rose M, Meurer SK, Kloten V, et al.ITIH5 induces a shift in TGF-beta superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death[J]. Mol Carcinog, 2018, 57(2): 167-181.
[11] Goyette MA, Duhamel S, Aubert L, et al.The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression[J]. Cell Rep, 2018, 23(5): 1476-1490.
[12] Xie F, Ling L, van Dam H, et al. TGF-beta signaling in cancer metastasis[J]. Acta Biochim Biophys Sin (Shanghai), 2018, 50(1): 121-132.
[13] Colak S, Ten Dijke P.Targeting TGF-beta Signaling in Cancer[J]. Trends cancer, 2017, 3(1): 56-71.
[14] Tauriello DVF, Palomo-Ponce S, Stork D, et al.TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis[J]. Nature, 2018, 554(7693): 538-543.
[15] Neuzillet C, Tijeras-Raballand A, Cohen R, et al.Targeting the TGFbeta pathway for cancer therapy[J]. Pharmacol Ther, 2015, 147: 22-31.
[16] Zhao M, Mishra L, Deng CX.The role of TGF-beta/SMAD4 signaling in cancer[J]. Int J Biol Sci, 2018, 14(2): 111-123.
[17] Levy L, Hill CS.Alterations in components of the TGF-beta superfamily signaling pathways in human cancer[J]. Cytokine Growth Factor Rev, 2006, 17(1-2): 41-58.
[18] Ismaeel A, Kim JS, Kirk JS, et al.Role of Transforming Growth Factor-beta in Skeletal Muscle Fibrosis: A Review[J]. Int J Mol Sci, 2019, 20(10): 2446
[19] Plein A, Fantin A, Ruhrberg C.Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability[J]. Microcirculation, 2014, 21(4): 315-23.
[20] Dhar K, Dhar G, Majumder M, et al.Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1[J]. Mol Cancer, 2010, 9: 209.
[21] Ball SG, Bayley C, Shuttleworth CA, et al.Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells[J]. Biochem J, 2010, 427(1): 29-40.
[22] Cao Y, Szabolcs A, Dutta S K, et al.Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype[J]. J Biol Chem, 2010, 285(41): 31840-3188.
[23] Cao S, Yaqoob U, Das A, et al.Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells[J]. J Clin Invest, 2010, 120(7): 2379-2394.
[24] Matkar PN, Singh KK, Rudenko D, et al.Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma[J]. Oncotarget, 2016, 7(43): 69489-69506.
[25] Glinka Y, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity[J]. J Leukocyte Biol, 2008, 84(1): 302-310.
[26] Wang Y, Cao Y, Yamada S, et al.Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-alpha Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1alpha and Mitochondrial Homeostasis[J]. Arterioscler Thromb Vasc Biol, 2015, 35(6): 1401-1412.
[27] Kalluri R, Weinberg RA.The basics of epithelial-mesenchymal transition[J]. J Clin Invest, 2009, 119(6): 1420-1428.
[28] Lamouille S, Xu J, Derynck R.Molecular mechanisms of epithelial-mesenchymal transition[J]. Nature Rev Mol Cell Biol, 2014, 15(3): 178-196.
[29] Vu T, Datta PK.Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis[J]. Cancers, 2017, 9(12): 171
[30] Sanchez-Tillo E, Liu Y, de Barrios O, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness[J]. Cell Mol Life Sci, 2012, 69(20): 3429-5346.
[31] Zhang Y, Weinberg R A.Epithelial-to-mesenchymal transition in cancer: complexity and opportunities[J]. Front Med, 2018, 12(4): 361-373.
[32] Wittmann P, Grubinger M, Groger C, et al.Neuropilin-2 induced by transforming growth factor-beta augments migration of hepatocellular carcinoma cells[J]. BMC Cancer, 2015, 15: 909.
[33] Nasarre P, Gemmill RM, Potiron VA, et al.Neuropilin-2 Is upregulated in lung cancer cells during TGF-beta1-induced epithelial-mesenchymal transition[J]. Cancer Res, 2013, 73(23): 7111-7121.
[34] Grandclement C, Pallandre JR, Valmary Degano S, et al.Neuropilin-2 expression promotes TGF-beta1-mediated epithelial to mesenchymal transition in colorectal cancer cells[J]. PloS One, 2011, 6(7): e20444.
[35] Clarke MF, Dick JE, Dirks PB, et al.Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells[J]. Cancer Res, 2006, 66(19): 9339-9344.
[36] Lapidot T, Sirard C, Vormoor J, et al.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice[J]. Nature, 1994, 367(6464): 645-648.
[37] Ishihara E, Takahashi S, Fukaya R, et al.Identification of KLRC2 as a candidate marker for brain tumor-initiating cells[J]. Neurol Res, 2019, 41(11): 1043-1049.
[38] Mani SA, Guo W, Liao MJ, et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4): 704-715.
[39] Jung HY, Fattet L, Yang J.Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis[J]. Clin Cancer Res, 2015, 21(5): 962-968.
[40] Gong C, Valduga J, Chateau A, et al.Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1[J]. Oncotarget, 2018, 9(20): 15312-15325.
[41] Glinka Y, Mohammed N, Subramaniam V, et al.Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-kappa B activation and tumor sphere formation[J]. Biochem Biophys Res commun, 2012, 425(4): 775-780.
[42] Chu W, Song X, Yang X, et al.Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma[J]. PLoS One, 2014, 9(7): e101931.
[43] Liu W, Wu T, Dong X, et al.Neuropilin-1 is upregulated by Wnt/beta-catenin signaling and is important for mammary stem cells[J]. Sci Rep, 2017, 7(1): 10941.
[44] Siegle JM, Basin A, Sastre-Perona A, et al.SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma[J]. Nat Commun, 2014, 5: 4511.
[45] Liu Q, Xu Y, Wei S, et al.miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1[J]. Biosci Rep, 2015, 35(4): e00229.
[46] Hamerlik P, Lathia JD, Rasmussen R, et al.Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth[J]. J Exp Med, 2012, 209(3): 507-520.
[47] Goel HL, Pursell B, Chang C, et al.GLI1 regulates a novel neuropilin-2/alpha 6 beta 1 integrin based autocrine pathway that contributes to breast cancer initiation[J]. EMBO Mol Med, 2013, 5(4): 488-508.
[48] Goel HL, Pursell B, Shultz LD, et al.P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer[J]. Cell Rep, 2016, 14(9): 2193-208.
[49] Goel HL, Gritsko T, Pursell B, et al.Regulated splicing of the alpha6 integrin cytoplasmic domain determines the fate of breast cancer stem cells[J]. Cell Rep, 2014, 7(3): 747-761.
[50] Lambert AW, Pattabiraman DR, Weinberg RA.Emerging Biological Principles of Metastasis[J]. Cell, 2017, 168(4): 670-691.
[51] Noumi T, Ishizaki M, Tanioka H, et al.A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery[J]. Kagaku Ryoho, 2019, 46(13): 2072-2074.
[52] Pan JX, Wang F, Ye LY.Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2016, 479(4): 610-614.
[53] Zhang L, Wang H, Li C, et al.VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/beta-Catenin Axis in Breast Cancer Cells[J]. Cell Physiol Biochem, 2017, 44(3): 1251-1262.
[54] Yue B, Ma JF, Yao G, et al.Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study[J]. Eur Rev Med Pharmacol Sci, 2014, 18(12): 1735-1741.
[55] Kamarulzaman EE, Vanderesse R, Gazzali AM, et al.Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application[J]. J Biomol Struct Dyn, 2017, 35(1): 26-45.
[56] Dong JC, Gao H, Zuo SY, et al.Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells[J]. J Cell Mol Med, 2015, 19(9): 2286-2295.
[57] Pagani E, Ruffini F, Antonini Cappellini GC, et al.Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness[J]. Int J Oncol, 2016, 48(4): 1581-1589.
[58] Kim YJ, Jung K, Baek DS, et al.Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin beta1-driven Src-Akt bypass signaling[J]. Oncogene, 2017, 36(18): 2543-2552.
[59] Rizzolio S, Cagnoni G, Battistini C, et al.Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies[J]. J Clin Invest, 2018, 128(9): 3976-3990.
[60] Rizzolio S, Battistini C, Cagnoni G, et al.Downregulating Neuropilin-2 Triggers a Novel Mechanism Enabling EGFR-Dependent Resistance to Oncogene-Targeted Therapies[J]. Cancer Res, 2018, 78(4): 1058-68.